Oliver Schoeffski

501 total citations
10 papers, 330 citations indexed

About

Oliver Schoeffski is a scholar working on Economics and Econometrics, General Health Professions and Immunology. According to data from OpenAlex, Oliver Schoeffski has authored 10 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Economics and Econometrics, 3 papers in General Health Professions and 3 papers in Immunology. Recurrent topics in Oliver Schoeffski's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Diabetes Treatment and Management (2 papers). Oliver Schoeffski is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Diabetes Treatment and Management (2 papers). Oliver Schoeffski collaborates with scholars based in Germany, Switzerland and Australia. Oliver Schoeffski's co-authors include Jörg C. Prinz, Matthias Augustin, Kristian Reich, Kristina M. Adams Waldorf, Erich Schubert, Christian Weber, J.-Matthias Graf von der Schulenburg, F Jost, Christoph Vauth and Reiner Leidl and has published in prestigious journals such as BMJ Open, Value in Health and PharmacoEconomics.

In The Last Decade

Oliver Schoeffski

10 papers receiving 318 citations

Peers

Oliver Schoeffski
Susan Oliver United Kingdom
E.A. Ba United States
Mark J. Integlia United States
Johanna Sheu United States
Arthur S. Hong United States
Oliver Schoeffski
Citations per year, relative to Oliver Schoeffski Oliver Schoeffski (= 1×) peers Sofia Löfvendahl

Countries citing papers authored by Oliver Schoeffski

Since Specialization
Citations

This map shows the geographic impact of Oliver Schoeffski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Schoeffski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Schoeffski more than expected).

Fields of papers citing papers by Oliver Schoeffski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Schoeffski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Schoeffski. The network helps show where Oliver Schoeffski may publish in the future.

Co-authorship network of co-authors of Oliver Schoeffski

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Schoeffski. A scholar is included among the top collaborators of Oliver Schoeffski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Schoeffski. Oliver Schoeffski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bushuven, Stefan, et al.. (2024). Learning motivation and self-assessment in health economics: a survey on overconfidence in healthcare providers. BMJ Open. 14(4). e079319–e079319. 3 indexed citations
2.
Heuvel, Dirk van den, Thomas Koch, Oliver Schoeffski, et al.. (2021). Improvement of transitional care from hospital to home for older patients, the TIGER study: protocol of a randomised controlled trial. BMJ Open. 11(2). e037999–e037999. 10 indexed citations
3.
Schoeffski, Oliver, et al.. (2015). Taking Medication Safely: Implementing And Developing A Medication Review Program In German Community Pharmacies Over 4 Years. Value in Health. 18(7). A542–A542. 1 indexed citations
4.
Rémy, Vanessa, et al.. (2012). Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model. Health Economics Review. 2(1). 19–19. 21 indexed citations
5.
Schulenburg, J. - Matthias Graf von der, Wolfgang Greiner, F Jost, et al.. (2008). German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus. Value in Health. 11(4). 539–544. 135 indexed citations
6.
Schoeffski, Oliver, Jörg C. Prinz, Kristian Reich, et al.. (2006). Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study. Dermatology. 212(2). 137–144. 88 indexed citations
7.
Shearer, Arran, A Bagust, Andreas Liebl, Oliver Schoeffski, & A Goertz. (2006). Cost-effectiveness of Rosiglitazone Oral Combination for the Treatment of Type 2 Diabetes in Germany. PharmacoEconomics. 24(S1). 35–48. 8 indexed citations
8.
Shearer, A, et al.. (2003). DB3 COST-EFFECTIVENESS OF ROSIGLITAZONE-METFORMIN COMBINATION IN OVERWEIGHT PATIENTS WITH TYPE 2 DIABETES IN GERMANY. Value in Health. 6(6). 607–607. 1 indexed citations
9.
Ruof, Jörg, et al.. (2001). Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis.. PubMed. 28(3). 657–61. 47 indexed citations
10.
Ruof, Jörg, Sonja Merkesdal, Oliver Schoeffski, et al.. (2001). Cost assessment instrument in rheumatology: evaluation of applied instrument characteristics.. PubMed. 28(3). 662–5. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026